Introduction: Who Should Undergo Diagnostics and When
An ischaemic stroke is a medical emergency that demands immediate attention. Anyone experiencing sudden symptoms such as facial drooping, arm weakness, slurred speech, vision changes, or loss of balance should seek emergency care right away. The brain begins to suffer damage within minutes when blood flow is interrupted, so every second counts in getting a proper diagnosis.[1][2]
You should call emergency services immediately if you or someone near you shows signs of stroke. Healthcare providers use a helpful memory tool called BE FAST to recognize warning signs: Balance problems, Eye changes, Face drooping, Arm weakness, Speech difficulty, and Time to call for help. Being able to tell medical staff when symptoms started is crucial, as this information helps doctors decide which treatments are safe to use.[2][15]
Even if symptoms disappear after a few minutes, you still need emergency evaluation. This temporary event is called a transient ischaemic attack (TIA), sometimes known as a mini-stroke. Though the effects fade quickly, a TIA is a serious warning sign that you are at very high risk of having a full stroke soon. People who have experienced a TIA need the same urgent diagnostic workup as those with stroke symptoms that persist.[2][24]
Healthcare providers cannot tell whether someone is having an ischaemic stroke or a hemorrhagic stroke (caused by bleeding in the brain) just by looking at symptoms. Both types can present similarly, but they require completely different treatments. This is why brain imaging is essential before any treatment begins. Giving the wrong treatment based on an incorrect assumption could be deadly.[1][8]
Diagnostic Methods to Identify Ischaemic Stroke
Initial Clinical Assessment
When someone arrives at the hospital with suspected stroke, doctors begin with a rapid clinical examination. They check vital signs including blood pressure, heart rate, breathing rate, and temperature. Healthcare providers also perform a neurological exam to assess how well different parts of the brain are functioning. This includes testing muscle strength, coordination, sensation, vision, speech, and mental awareness.[24]
A common tool used during this assessment is the National Institutes of Health Stroke Scale (NIHSS), which measures the severity of stroke symptoms. This standardized scoring system helps medical teams communicate clearly about a patient’s condition and track changes over time. The score guides decisions about which treatments might be appropriate.[4]
Doctors also gather crucial information about when symptoms started, what the person was doing at the time, and their medical history. They ask about risk factors such as high blood pressure, diabetes, heart conditions like atrial fibrillation (an irregular heartbeat), high cholesterol, and whether the person smokes or has had previous strokes. Understanding a patient’s medication list is important too, especially if they take blood thinners or have bleeding disorders.[6][7]
Brain Imaging: The Essential First Step
The most important diagnostic test for suspected stroke is brain imaging. This must happen quickly—ideally within minutes of arriving at the emergency department. The primary purpose is to determine whether the stroke is caused by a blocked blood vessel (ischaemic) or bleeding (hemorrhagic), since these require opposite treatments.[10]
A computed tomography scan, commonly called a CT scan, is usually the first imaging test performed. This quick, non-invasive test uses X-rays to create detailed pictures of the brain. A CT scan is excellent at showing fresh bleeding and can also reveal areas of brain tissue that have already been damaged by lack of blood flow. The test takes only a few minutes and doesn’t require the patient to be awake or cooperative, which makes it ideal for emergency situations.[4][10]
In some hospitals, doctors may perform a magnetic resonance imaging scan, or MRI, instead of or in addition to CT. MRI uses powerful magnets and radio waves rather than X-rays to create even more detailed images of the brain. A special type of MRI called diffusion-weighted imaging is particularly sensitive at detecting areas of brain tissue affected by stroke, sometimes showing damage within minutes of symptom onset. However, MRI takes longer to perform and is not available in all emergency departments.[4]
Blood Vessel Imaging
After the initial brain scan, doctors often need to look at the blood vessels themselves to find where the blockage is located. This information helps them decide whether certain advanced treatments might help. Several imaging techniques can show the blood vessels in detail.[8]
A CT angiogram (CTA) involves injecting a special dye into the bloodstream and then taking CT images. The dye makes blood vessels visible on the scan, allowing doctors to see exactly where a clot is blocking flow. This test can reveal obstructions in large vessels feeding the brain, which is important information for planning treatment.[8]
Alternatively, doctors might perform MR angiography (MRA), which uses MRI technology to visualize blood vessels. Like CT angiography, this can show where blood flow is blocked. Some MRA techniques require injecting contrast dye, while others do not.
For patients with suspected blockages in the arteries of the neck that supply blood to the brain, doctors may order an ultrasound examination. A carotid ultrasound uses sound waves to create images of the carotid arteries in the neck. This painless test can reveal whether these major vessels have narrowing from plaque buildup or other abnormalities that might have caused or contributed to the stroke.[7]
Blood Tests
While imaging provides the most critical information, blood tests also play an important supporting role in stroke diagnosis. Medical teams typically draw blood as soon as possible after arrival to check several factors that affect treatment decisions and help identify underlying causes.[10]
Standard blood work includes checking blood counts, blood sugar levels, kidney function, and liver function. Doctors measure clotting factors to understand how quickly the patient’s blood clots, which is important when considering treatments that affect clotting. Electrolyte levels and markers of heart damage are also routinely checked.[4]
Blood tests help doctors rule out other conditions that might mimic stroke symptoms, such as very low blood sugar, infections, or certain metabolic problems. They also identify risk factors and underlying conditions that may have caused the stroke, such as diabetes or cholesterol problems.
Heart Monitoring and Testing
Because many ischaemic strokes are caused by blood clots that form in the heart and then travel to the brain, doctors need to evaluate heart function. An electrocardiogram (ECG or EKG) records the electrical activity of the heart and can detect irregular heart rhythms, particularly atrial fibrillation, which is a major risk factor for stroke.[6][7]
An echocardiogram, or ultrasound of the heart, may be performed to look for clots inside the heart chambers, problems with heart valves, or structural abnormalities that could allow clots to pass from one side of the heart to the other. Sometimes doctors perform a specialized version called a transesophageal echocardiogram, where an ultrasound probe is passed down the throat to get very close-up images of the heart structures.
Continuous heart monitoring may continue for hours or even days after the initial event to catch irregular rhythms that come and go. Some patients wear portable monitors that record heart activity over extended periods.
Additional Specialized Tests
Depending on a patient’s age, risk factors, and specific situation, doctors might order additional tests to investigate less common causes of stroke. Younger patients without typical risk factors might need tests for blood clotting disorders, inflammatory conditions affecting blood vessels, or genetic conditions that increase stroke risk.[4]
Tests might include detailed blood work looking for unusual antibodies, genetic testing, or imaging of blood vessels throughout the body. These specialized investigations help doctors understand why a stroke occurred and how to prevent another one.
Diagnostics for Clinical Trial Qualification
Clinical trials testing new treatments for ischaemic stroke use specific diagnostic criteria to determine which patients can participate. These criteria ensure that trials include the right patients and can accurately measure whether new treatments work. Understanding these requirements helps explain how researchers study stroke treatments systematically.
Imaging Requirements for Trial Entry
Most clinical trials require brain imaging to confirm that a patient has had an ischaemic stroke rather than a hemorrhagic stroke or another condition. Trials typically specify exactly which type of imaging is acceptable—many require both CT and MRI scans to precisely measure the size and location of the stroke damage.[4]
Advanced imaging techniques like CT angiography or MR angiography are often required to document exactly where blood vessels are blocked. Some trials focus specifically on patients with blockages in large vessels, while others might include people with small vessel strokes. The imaging results determine eligibility.[8]
Trials testing treatments that must be given very quickly often use imaging to measure how much brain tissue has already died versus how much is still salvageable. Special MRI sequences or CT perfusion studies can show areas where blood flow is reduced but cells are still alive. These “at risk” areas, sometimes called the ischaemic penumbra, might still be saved if blood flow is restored quickly.[13]
Time Windows and Symptom Onset
One of the most important eligibility criteria for stroke trials is time—specifically, how long it has been since symptoms started. Many trials of clot-dissolving drugs or devices to remove clots have strict time limits, often requiring treatment within three, four-and-a-half, six, or twenty-four hours depending on the specific intervention being studied.[11][14]
Knowing the exact time symptom onset is critical. For people who wake up with stroke symptoms, determining when the stroke occurred can be challenging. Some trials use special imaging techniques to estimate timing, comparing different types of MRI sequences to see how old the stroke damage is.
Stroke Severity Measurements
Clinical trials typically use standardized scales to measure stroke severity, most commonly the National Institutes of Health Stroke Scale mentioned earlier. Trials often specify a range of severity scores—for example, only including patients with moderate to severe strokes, or specifically studying mild strokes. This ensures the trial tests the treatment in the appropriate patient population.[4]
Researchers assess not just the initial severity but also monitor how patients improve or worsen over time using repeated scoring. This provides objective data about whether a treatment works.
Medical History and Laboratory Values
Trial protocols specify which medical conditions or laboratory results would exclude someone from participating. For example, trials of blood thinners might exclude people with recent surgery, bleeding disorders, or very low platelet counts. Trials might also require normal or near-normal kidney or liver function, or exclude people taking certain medications that could interfere with the experimental treatment.[4]
Blood tests checking clotting function, kidney health, liver health, blood counts, and metabolic factors are standard parts of trial screening. These results help researchers ensure patient safety and avoid enrolling people who might be harmed by the experimental treatment.
Age and Functional Status
Some trials have age restrictions, though many now include elderly patients since stroke is common in older adults. Researchers may also assess a patient’s functional status before the stroke—how independent they were with daily activities. This helps measure whether treatments help patients return to their previous level of function.
Follow-up Assessments
Clinical trials require repeated diagnostic tests to monitor outcomes. Participants typically undergo follow-up imaging days or weeks after treatment to see how much brain damage occurred and whether blood flow was successfully restored. They also complete repeated neurological assessments and functional evaluations over weeks to months to measure recovery.[4]
These standardized follow-up protocols generate the data that tells researchers whether a new treatment is safe and effective. The information gathered from trial participants helps improve care for all future stroke patients.


